2Nov 2017 Teva Announces Completion of Plan B One-Step® Divestiture to Foundation Consumer Healthcare Read More >
30Oct 2017 Kåre Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017 Read More >
26Oct 2017 Teva to Highlight Asthma Data at the 2017 American College of Allergy, Asthma and Immunology Annual Scientific Meeting Read More >
19Oct 2017 Teva to Highlight New Data in Multiple Sclerosis at Joint ECTRIMS – ACTRIMS Congress in Paris Read More >
17Oct 2017 Teva Announces Submission of Biologics License Application for Fremanezumab to the U.S. FDA Read More >
5Oct 2017 Teva Announces tomy’s Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy Read More >